Cancer Biologics Market Detailed Analysis
Added: (Sat Feb 20 2021)
Pressbox (Press Release) -
Cancer Biologics Market 2021
The global Cancer Biologics Market was valued at USD 31,179.71 million in 2019 and is expected to grow at 6.7% CAGR during the forecast study period, and is expected to reach USD 1789.59 million.
Get a Sample copy of this report :
https://straitsresearch.com/report/Cancer Biologics-Market/request-sample
Key Market Players
Hoffmann-La Roche Ltd, Novartis AG, Eli Lilly and Company, Sanofi, CELGENE CORPORATION, Pfizer Inc., Bayer AG, Johnson and Johnson Services, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., and Amgen Inc.
Recent Developments
In December 2019, Biocon and its partner Mylan collaboratively launched a cancer drug Ogivri, a biosimilar to Herceptin, in the U.S. The drug is available in a 420mg multi-dose vial and a 150mg single-dose vial to treat all types of breast cancer and metastatic stomach cancer.
In November 2018, Roche and Abbvie received FDA approval for Venclexta, a BCL-2 inhibitor effective in treating leukemia. Venclexta is jointly commercialized by Abbvie and Genetech, a part of Roche.
Global Cancer Biologics Market: Market Segmentation
By Type
Monoclonal Antibodies
Growth Factor
Blood & Blood Products
Vaccines & Toxoids
Others
Years that have been considered for the study of this report are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year: 2021 to 2029
Regional Segmentation:
North America (The US, Canada, and Mexico)
Europe (Germany, France, the UK, and Rest of the World)
Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
Latin America (Brazil and Rest of Latin America.)
Middle East & Africa (Saudi Arabia, the UAE, South Africa, and Rest of Middle East & Africa)
Additionally, the analysis also delivers a comprehensive review of the crucial players on the Cancer Biologics Market along with their company profiles, SWOT analysis, latest advancement and business plans.
The analysis objectives of the report are:
To analyze the Global Cancer Biologics Market concerning growth trends, prospects and also their participation in the entire sector.
To examine and study the Global Cancer Biologics Market size (volume and value) form the company, essential regions/countries, products and applications, background information and also predictions to 2029.
Primary worldwide Global Cancer Biologics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans for the next coming years.
To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.
Explore Full Report with Detailed TOC, Charts, Tables and Figures@
https://straitsresearch.com/report/Cancer Biologics-Market
Would you like to discuss Cancer Biologics Market challenges with the experts at Straits Research
For more details, please contact us -
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846
Website:https://straitsresearch.com